Lifestyle factors influence both gut microbiome composition and host metabolism, yet their combined and mediating effects on host phenotypes remain poorly characterized in cardiometabolic populations. In 1,643 participants from the MetaCardis study, we developed a composite lifestyle score (QASD: dietary quality, physical activity, smoking, and diet diversity) that outperformed individual lifestyle variables in explaining microbial gene richness and exhibited a significant impact on the gut microbiome composition. While bidirectional pathways linking the QASD score, host phenotypes, and microbiome composition were assessed, causal inference-based mediation analyses indicated stronger effects when the microbiome was modeled as the mediator variable, particularly in relation to the insulin resistance-associated profile. Microbiome gene richness emerged as a key mediator explaining 27.8% of QASD score's effect on the insulin resistance marker (HOMA-IR), while no significant mediation was observed on BMI. Extended mediation analyses on microbial species and serum metabolomics deconfounded for drug use and clinical profiles identified 47 mediations where microbial taxa mediated more than 20% of the effect of the QASD score on serum metabolites associated with insulin resistance. Notably, several Faecalibacterium lineages enriched in individuals with high QASD score played a significant mediatory role in increasing the serum biomarkers of microbiome diversity (as cinnamoylglycine or 3-phenylpropionate). Conversely, elevated levels of secondary bile acids in individuals with low QASD scores were strongly mediated by high levels of Clostridium bolteae. These findings highlight distinct and clinically relevant microbiome pathways linking lifestyle behaviors to cardiometabolic risks.One sentence summary:The gut microbiome mediates the impact of diet quality and diversity, physical activity and smoking status - combined in a composite lifestyle score - on cardiometabolic phenotypes.
Verlagsort530 Walnut Street, Ste 850, Philadelphia, Pa 19106 Usa
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum0000-00-00
Veröffentlichungsnummer
Anmeldedatum0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
BegutachtungsstatusPeer reviewed
Institut(e)Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
FörderungenIsite ULNE Medical Research Council Centre for Neurodevelopmental Disorders Agence Nationale de la Recherche European Metropolis of Lille EIC-pathfinder National Center for Diabetes Precision Medicine NIHR Imperial Biomedical Research Centre European Commission Hauts-de-France Regional Council Guts UK Deutsche Forschungsgemeinschaft Deutsches Zentrum fr Herz-Kreislaufforschung Fondation Leducq Medical Research Council Diabetes UK European Commision European Union (FEDER) Wellcome Trust European Central Bank